Eli Lilly plans €400m Irish plant that will create 800 jobs

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines, in

Arecor heads for London Stock Exchange with drug reformulati...

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed dr

Ireland is open: The biologics boom boosting the Irish econo...

The life sciences industry has an important role in the Irish economy, with sectors such as biologics booming across the country.

Nine for 2021: Addressing the pandemic legacy

In this second 'Nine for 2021' article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact pharma in 2021: t

Pharma fury as Trump's team reneges on biologic patent rules...

A key part of president Donald Trump’s strategy to cut drug prices was to attack global “freeloading” for pharmaceuticals, targeting countries pushing back against pharma companies trying t

US eyes faster launch for biosimilars in North American trad...